FIU Discovery

Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy

All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy.  BIOCONJUGATE CHEMISTRY.  34:1122-1129.

Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1.  SCIENTIFIC REPORTS.  13.

Restoring the neuroprotective capacity of glial cells under opioid addiction

Intersection of Inorganic Chemistry and Nanotechnology for the Creation of New Cancer Therapies

Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress.  ACS NANO.  15:15741-15753.

Blending of Designer Synthetic Polymers to a Dual Targeted Nanoformulation for SARS-CoV-2 Associated Kidney Damage

Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration.  ACS NANO.  14:11055-11066.

Inhibition of Amyloid-Beta Production, Associated Neuroinflammation, and Histone Deacetylase 2-Mediated Epigenetic Modifications Prevent Neuropathology in Alzheimer's Disease in vitro Model.  FRONTIERS IN AGING NEUROSCIENCE.  11.

MRI-Guided, Noninvasive Delivery of Magneto-Electric Drug Nanocarriers to the Brain in a Nonhuman Primate.  ACS APPLIED BIO MATERIALS.  2:4826-4836.

Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus.  ACS NANO.  13:11034-11048.

Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  115:E12333-E12342.

A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation.  BIOMATERIALS.  187:117-129.

Reduction of Cisplatin-Induced Ototoxicity without Compromising Its Antitumor Activity.  BIOCHEMISTRY.  57:6500-6513.

Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.  NANOSCALE.  10:366-377.

A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.  MOLECULAR CANCER THERAPEUTICS.  16:625-636.

Photocurrent imaging of phase segregation in a ternary polymer blend induced via a non-solvent route

Controlled Multi-functionalization Facilitates Targeted Delivery of Nanoparticles to Cancer Cells.  CHEMISTRY-A EUROPEAN JOURNAL.  22:1415-1423.

Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.  NATURE COMMUNICATIONS.  6.

Evaluation of nanoparticle delivered cisplatin in beagles.  NANOSCALE.  7:13822-13830.

Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation.  ADVANCED HEALTHCARE MATERIALS.  3:1448-1456.

Exploring Strain-Promoted 1,3-Dipolar Cycloadditions of End Functionalized Polymers.  CHEMISTRY-A EUROPEAN JOURNAL.  20:8753-8760.

Multifunctionalization of Polymers by Strain-Promoted Cycloadditions.  MACROMOLECULES.  46:7759-7768.

Nanocarriers for Tracking and Treating Diseases.  CURRENT MEDICINAL CHEMISTRY.  20:3500-3514.

α_Vβ₃ Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug.  ACS NANO.  6:4530-4539.

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  108:1850-1855.

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  107:17939-17944.

Structure-Reactivity Scales in Carbocationic Polymerizations.  MACROMOLECULES.  41:9025-9029.

Relative reactivities of isobutylene, styrene, and ring-substituted styrenes in cationic polymerizations.  MACROMOLECULES.  41:3842-3851.

Effect of surfactants on the fluorescence spectra of water-soluble MEHPPV derivatives having grafted polyelectrolyte chains

An efficient bulk-heterojunction photovoltaic cell based on energy transfer in graded-bandgap polymers.  ADVANCED FUNCTIONAL MATERIALS.  17:226-232.

Tunable two-colour patterning of MEHPPV from a single precursor.  JOURNAL OF MATERIALS CHEMISTRY.  17:1682-1686.

Segmented poly [2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylene vinylene] via xanthate and dithiocarbamate precursors: A comparative study of thermal eliminations.  JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY.  41:3929-3940.

Chapter 10 Recent updates on the emerging role of vegetable oils in the development of hydrogel technology for biomedical applications.  131-138.

Nanoparticles for Targeted and Temporally Controlled Drug Delivery.  9-29.

Biodistribution and Pharmacokinetics of Nanoprobes.  75-104.

Anti-HIV and Anti-inflammasome Activity of a Novel Chiral Potent Endocannabinoid Ligand (R)- N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315).  JOURNAL OF NEUROVIROLOGY. S1-S2.

Blood-brain barrier crossing nanoparticle for the delivery of antiretrovirals for targeting HIV-infected brain reservoirs.  ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Copper-free clickable initiators and chain transfer agents for ROP and RAFT polymerizations.  ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Multifunctionalization of polymers through sequential copper-free click reactions.  ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

POLY 101-Relative reactivity of cationic monomers: Isobutylene, styrene and ring substituted styrenes.  ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Grafting functional handles on to MEHPPV - Possible application for sensing.  320-323.

Modulating phase-separation in blends of MEHPPV-x with different conjugation lengths.  295-298.

Correction to "Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress"..  ACS NANO. 22608.

Drug Delivery to the Brain: Recent Advances and Unmet Challenges

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases.  4354-4367.

Recent Advances in Nanotherapeutics for Neurological Disorders.  ACS APPLIED BIO MATERIALS. 2614-2621.

Multi-functional auto-fluorescent nanogels for theranostics.  JOURNAL OF NEUROVIROLOGY. 252-257.

Cannabidiol for neurodegenerative disorders: A comprehensive review

Controlled release nanoplatforms for three commonly used chemotherapeutics

Recent advances, status, and opportunities of magneto-electric nanocarriers for biomedical applications

Nanotechnology inspired tools for mitochondrial dysfunction related diseases.  ADVANCED DRUG DELIVERY REVIEWS. 52-69.

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.  NANOMEDICINE. 269-285.

Targeted nanoparticles in mitochondrial medicine.  315-329.